Investor Ideas #Potcasts, #Cannabis News and Stocks on the Move: (CSE: $AGRA.C) (CSE: $IAN.C) (CSE: $TRUL.C) and (NYSE: $ACB) (TSX: $ACB.TO)
Delta, Kelowna, BC –April 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/04041AGRA-IAN-TRUL-ACB.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from AgraFlora Organics International Inc. (CSE: AGRA) (OTC: PUFXF), iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF), Trulieve Cannabis Corp. (CSE: TRUL) (OTC:TCNNF) and Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB).
AgraFlora Organics International Inc., a growth oriented and diversified international cannabis company, and Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF), a developer of MedTech innovation, jointly referred to as the "Partners", announced the execution of a binding letter of intent to bring Glow LifeTech Ltd., the cannabis technology joint venture, public by way of reverse takeover. In December 2018 the Partners jointly announced the formation of Glow to identify and develop technologies within the global cannabis sector.
"Our initial due diligence into the cannabis technology sector has indicated there is significant demand for new technologies in all levels of the emerging cannabis marketplace," said Derek Ivany, President and CEO, AgraFlora Organics International. "AgraFlora's first venture in cannabis related technology resulted in successful spin-off of the now publicly traded Cannvas MedTech to the benefit of shareholders. Taking Glow LifeTech public through a reverse takeover will provide the company with necessary capital to bring new and proprietary technology to market, again to the benefit of all shareholders. I look forward to working with the leadership team to execute on an aggressive business strategy and finalizing the proposed transaction with Ateba."
iAnthus Capital Holdings, Inc., which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, announced a licensing agreement entered into between its U.S. subsidiary and Blissiva, a women-owned, Maryland-based company specializing in producing and distributing medical cannabis products specifically formulated for women. As per the licensing agreement, iAnthus will manufacture, market and sell a variety of Blissiva products in its markets, with initial launch in Maryland scheduled for April 20, 2019. Additionally, iAnthus has the exclusive right to launch Blissiva in its ten other existing states and across the United States.
Blissiva was founded by obstetrician gynecologist Dr. Leslie Apgar and serial entrepreneur Gina Dubbé who have a mission to make medical cannabis more accessible and desirable to women. Blissiva's first product, the Balance Pen, was formulated specifically to help women combat stress and anxiety. The pen first came to market in October 2018 and sold out in just six weeks of its anticipated 12 week run. Blissiva is developing a line of additional products designed for women's health, wellness and recreation.
"We are extremely proud to partner with Blissiva in launching female-focused cannabis products into the market. Women represent one of the largest and fastest growing demographics of consumers in this industry, and there is currently a lack of products specifically designed to address their health and wellness needs. We believe that women should be able to 'have it all,' and I'm excited to be working with Dr. Apgar, a groundbreaking expert in women's health, to fill the gap in the industry," said Beth Stavola, Chief Strategy Officer of iAnthus.
Leading national cannabis company Trulieve Cannabis Corp. announced today that it has signed an agreement with California-based Blue River Extracts & Terpenes™ to bring their award-winning terpene extracts and other trademark branded products to Florida's growing patient base.
Blue River™ is an industry-leading cannabis company that has focused on the development of full spectrum solvent-less cannabis derived terpenes and began utilizing terpenes with advanced mechanical extraction techniques to create an array of award winning branded products including, Rosin, Dry Sift Sap, Vape Cartridges, CBD Crystalline, Rosin Sauce, THCa, Flan™, and Jelly™, which earned them over 50 cannabis awards to date. Blue River™ continued to shape the landscape of the cannabis industry through their proprietary solvent-less extraction technology and helped to popularize full-spectrum solvent-less products with the use of cannabis derived terpenes.
"Blue River™ has truly set the standard for innovation and excellence with their terpene technology, creating products that are high-quality and one-of-a-kind. Their dedication to quality, excellence, and standardization has changed the landscape of the cannabis market and matches Trulieve's own dedication to the same standards," said Trulieve CEO Kim Rivers. "Their products are an effective, reliable option for patients seeking relief in innovative ways."
Aurora Cannabis Inc. today announced that the Company has appointed Carey Squires as its Executive Vice President of Corporate Development and Strategy. In this newly created role, reporting to the Executive Chairman, Mr. Squires in collaboration with senior executives across the company will focus on global growth and partnership strategies and investor development.
Mr. Squires comes to Aurora with global investment banking experience, having most recently served as Managing Director and Co-Head of Equity-Linked Capital Markets for BMO Capital Markets. In this role, he successfully led the financing for a number of issuers, including Aurora's recent convertible notes offering. Mr. Squires received a B.Sc from the University of British Columbia as well as an MBA from the Rotman School of Management at the University of Toronto.
"With deep experience in the U.S. and Canadian capital markets, Carey has been a trusted advisor to Aurora on a variety of growth initiatives, including our recently successful capital raise," said Michael Singer, Executive Chairman of Aurora. "In this new position, Carey will be a core member of Aurora's senior management team, executing on the development of key strategic initiatives, including partnerships and M&A opportunities. We look forward to working closely with Carey to leverage his extensive knowledge in the execution of our investor development, international growth and partnership strategies, sourcing potential accretive opportunities in the global cannabis industry and negotiating favourable business transactions."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment